Ashley Bird
Emergency Medical Services · Kingsport, TNNPI 1376133033
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 173 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,523, more than ten times the $72 reported in 2022.
Across 173 payments — averaging $18.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$471
- Novo Nordisk$361
- Lilly USA, LLC$325
- AbbVie$247
- GSK$228
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$219
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,15598%
- Education$702%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 16 | $471 |
| Novo Nordisk | 21 | $361 |
| Lilly USA, LLC | 18 | $325 |
| AbbVie | 21 | $247 |
| GSK | 13 | $228 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $219 |
| Bayer | 11 | $187 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $151 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $148 |
| Pfizer | 9 | $141 |
| Astellas Pharma US Inc | 2 | $89 |
| Lundbeck LLC | 4 | $80 |
| E.r. Squibb & Sons, L.L.C. | 4 | $74 |
| Dexcom, Inc. | 2 | $71 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| Johnson & Johnson | 4 | $53 |
| Inogen, Inc. | 3 | $48 |
| Boston Scientific | 1 | $36 |
| Medtronic | 1 | $23 |
| Boehringer Ingelheim | 1 | $23 |
| Abbott | 1 | $22 |
| Novartis | 1 | $22 |
| CSL Behring | 1 | $20 |
| Bioxcel Therapeutics, Inc. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Exact Sciences | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Corcept Therapeutics | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Amgen | 1 | $14 |
| Dynavax Technologies Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few emergency medical services providers in Tennesseeto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 49 | $50,086 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $10,208 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 75 | $2,262 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 99 | $2,172 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 50 | $1,528 |
| Omeprazole | 136 | $1,195 |
| Rosuvastatin Calcium | 45 | $937 |
| Gabapentin | 91 | $805 |
| Fluticasone Propionate | 44 | $792 |
| Levothyroxine Sodium | 105 | $775 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 71 | $773 |
| Ventolin HfaAlbuterol Sulfate | 11 | $677 |
| Atorvastatin Calcium | 75 | $634 |
| Potassium Chloride | 35 | $616 |
| Esomeprazole Magnesium | 18 | $567 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $141 | $50,08649 claims |
| AstraZenecaBreztri Aerosphere | $471 | $10,20816 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few emergency medical services providers in Tennesseeon file to place this against a meaningful peer group, so we don't.
Other emergency medical services in Kingsport
- David LienHermitage$950
- Leslie LenningHermitage$928
- Bryan SharpeHermitage$808
- David LanierGallatin$709
- James DavenportNashville$501
- Steven HaywoodJohnson City$476
- Kevin BeierNashville$383
- Bradley HooverHermitage$381
- Roderick BahnerHermitage$247
- Jeffry GreenleeHermitage$113
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.